SPSilvia Portugal

Silvia Portugal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvia Portugal has a total of 411 co-authors. Here are the top co-authors by number of shared publications:

  • Boubacar Traore

    Malaria Research and Training Centre, Mali International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako , Bamako

    16 shared publications
  • Peter D. Crompton

    Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health

    14 shared publications
  • Aissata Ongoiba

    Affiliation Mali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali

    13 shared publications
  • Kassoum Kayentao

    Affiliation Mali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali

    12 shared publications
  • Didier Doumtabe

    Affiliation Mali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali

    10 shared publications
  • Safiatou Doumbo

    Affiliation Mali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali

    10 shared publications

Latest Publications

  • Open Access

    Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa

    by Julia Zerebinski, Ioanna Broumou, Kelvin M Kimenyi, Eleni Aklillu, Carolina M Andrade, Hamza Babiker, Philip Bejon, Mariama K Cherif, Peter D Crompton, Cláudia Fançony, et al.

    Background: A multicomponent vaccine is increasingly recognized as a necessary tool to control and eliminate malaria globally. However, genetic diversity in Plasmodium falciparum poses a significant challenge, particularly for blood-stage antigens associated with protective immunity. Individuals in endemic regions acquire clinical immunity without exposure to all antigenic variants, suggesting that a deeper understanding of antigen diversity could inform more effective vaccine strategies. Methods: The genetic diversity of the polymorphic gene locus for merozoite surface protein 2 was assessed with nested polymerase chain reaction and capillary electrophoresis fragment sizing in P falciparum isolates from 34 countries across sub-Saharan Africa. High fidelity long-read sequencing was used to investigate sequence diversity within msp2 variants. Results: We successfully genotyped msp2 from 2761 P falciparum–positive samples using capillary electrophoresis, identifying 412 distinct msp2 size variants. Several msp2 size variants were consistently overrepresented across geographical regions, transmission intensities, and time points. These variants comprised multiple unique sequences, of which several were geographically and temporally widespread. Nucleotide and amino acid sequences showed high diversity without geographical clustering. Conclusions: This study provides a comprehensive assessment of msp2 diversity across sub-Saharan Africa. The widespread prevalence of certain variants of this highly polymorphic antigen suggests possible structural constraints or selective advantages for the parasite. Maintenance of specific gene lengths and sequences across diverse settings highlights their potential as targets for next-generation, multicomponent malaria vaccines.

  • Open Access

    Identification of cross-stage, cross-species malaria CD8+ T cell antigens

    by Camila R. R. Barbosa, Luna B. de Lacerda, Paulo J. G. Bettencourt, David Morrow, Dhelio B. Pereira, Maya Aleshnick, Julie L. Mitchell, Nicholas C. Poulton, Cristopher Gomes, Lídia P. B. Cordeiro, et al.

    A major limitation on the development of a malaria vaccine is the lack of validated T cell epitope targets. Plasmodium falciparum is the most prevalent malaria parasite affecting humans in Africa, whereas Plasmodium vivax is more widespread and is the main species that causes malaria in the Americas and Asia1. P. vivax exclusively infects peripheral-blood reticulocytes, which retain RNA and the capacity for host protein synthesis2. We previously reported that reticulocytes infected with P. vivax express human leukocyte antigen class I (HLA-I), which enables recognition and killing of the parasite by CD8+ T cells3. Here we use immunopeptidomics to identify Plasmodium-antigen-derived peptides presented by HLA-I on infected reticulocytes. We identified 453 unique peptides, mapping to 166 proteins. Seventy-five antigens were housekeeping proteins that are constitutively expressed at multiple stages of the parasite’s life cycle and are highly conserved between Plasmodium species. Identical peptides were presented in different individuals by the same or distinct HLA-A, HLA-B and HLA-C alleles, as well as by the non-classical HLA-E allele. The antigenicity of the newly identified epitopes was validated in samples from both P. vivax-infected and P. falciparum-infected individuals. Furthermore, T cell responses to several of these antigens were observed in the blood and liver of non-human primates after infection with Plasmodium or immunization with attenuated parasites. Two antigens also induced protective CD8+ T cell-mediated immunity in rodents. Thus, these antigens have the potential for use in a cross-stage and cross-species malaria vaccine.


  • Top Cited Papers
    Open Access

    Continental-scale genomic surveillance of Plasmodium falciparum malaria across sub-Saharan Africa with rapid nanopore sequencing

    by Mulenga Mwenda, Karolina Mosler, Bernd Bohmeier, Miriam Chomba, Welmoed van Loon, Brenda Mambwe, Amy Gaye, Adedolapo Olorunfemi, Salma Suliman, Nassandba Julien Yanogo, et al.

    In sub-Saharan Africa, continental-scale genomic surveillance of Plasmodium falciparum malaria is needed to track the spread of drug and diagnostic resistance, as well as monitor parasite evolutionary responses to vaccine rollout. Yet continental-scale implementation is hindered by a lack of genomic approaches suitable for local laboratories, and the vastness of the continent. Here, we initiate a decentralised scale-up of P. falciparum genomic surveillance by locally sequencing and analysing 1065 samples across six African countries in one year. We achieve this with a novel nanopore sequencing protocol that is rapid (~5 hr) and cost-effective (<$25 USD/sample), providing surveillance of antimalarial drug resistance genes, hrp2/3 deletions, the vaccine target csp , and the polymorphic gene ama1 . We couple this to a laptop-based bioinformatics dashboard that runs offline and displays mapping and variant calling results in real-time. We demonstrate robust sequencing coverage across parasitemia levels and laboratories, accurate identification of antimalarial resistance markers and hrp2/3 deletions; and, with a novel variant caller, sensitive detection of mutations carried by minor clones. Our approach will accelerate genomic surveillance of P. falciparum malaria across sub-Saharan Africa at a time of urgent need.


  • Open Access

    Uncovering the genetic diversity of the malaria parasite antigen MSP2 across Sub-Saharan Africa

    by Julia Zerebinski, Ioanna Broumou, Kelvin M. Kimenyi, Eleni Aklilu, Carolina M. Andrade, Hamza Babiker, Philip Bejon, Mariama K. Cherif, Peter D. Crompton, Cláudia Fançony, et al.

    Genetic diversity in Plasmodium falciparum poses a significant challenge to malaria control and elimination. This is particularly important for developing fully efficacious vaccines, which should include valuable blood stage antigens. Several antigen candidates are highly diverse and require further understanding. We surveyed the genetic diversity of the highly polymorphic merozoite surface protein 2 (MSP2) in 2761 P. falciparum isolates collected across Sub-Saharan Africa. Using PCR-based genotyping and long-read sequencing, we identified extensive diversity among msp2 size variants and sequences. Some size variants were more prevalent than others across different geographical regions, transmission intensities, and time points. These variants comprised multiple unique sequences, of which several were geographically and temporally widespread. Our study reveals greater msp2 sequence diversity than previously known, while also identifying interesting similarities in sequence and gene length across Sub-Saharan Africa. These findings support the further exploration of common msp2 variants in relation to parasite virulence and vaccine development.


  • Open Access

    Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases

    by Sukai Ceesay, Martin Kampmann, Lasse Votborg-Novél, Helle Smedegaard Hansson, Rasmus Weisel Jensen, Manuela Carrasquilla, Hamidou Cisse, Louise Turner, Usama Dabbas, Christina Ntalla, et al.

    In seasonal transmission areas, clinical malaria occurs during the wet season when mosquitoes are present, while in the dry season, malaria transmission is interrupted and clinical cases are rare. In Mali, Plasmodium falciparum can persist in low parasitaemic asymptomatic individuals through the six-month dry season and shows circulation of more developed parasite stages compared to clinical malaria cases, indicative of reduced cytoadhesion of infected erythrocytes. How prolonged circulation of infected erythrocytes is achieved remains unknown. Here, we explored var gene expression in subclinical infections and clinical malaria cases of Malian children, collected during the dry and wet seasons. We sequenced expressed var DBLα-tags, used bioinformatic tools to predict their domain composition, binding phenotype and upstream sequence type; and determined their relationship to seasonality and clinical presentation. We found that parasites of asymptomatic infections expressed fewer var genes, with a larger proportion of var transcripts attributed to one or a few vars. In contrast, clinical cases exhibited expression of many var genes at lower proportions. We found that parasites of asymptomatic carriers expressed a mixture of CD36- and EPCR-binding PfEMP1, which changed over time. We confirmed that vars encoding CD36-binding PfEMP1 dominated in non-severe malaria cases, and found no significant difference in expressed var types between dry and wet seasons. Asymptomatic carriers were older, had higher titers of anti-P. falciparum antibodies, and broader reactivity to PfEMP1, suggesting that host immunity was the main determinant limiting var transcript variation in asymptomatic carriers. However, qRT-PCR analyses also indicated higher total var transcript levels in malaria cases compared to asymptomatic carriers, suggesting that in addition to the parasite’s switching and the host’s immune selection of expressed var genes, parasites able to sustain long-term infections may be poised for reduced PfEMP1 expression.


  • Open Access

    Seasonal transcriptional profiling of malaria parasites using a new single-cell atlas of a Malian Plasmodium falciparum isolate

    by Lasse Votborg-Novél, Martin Kampmann, Manuela Carrasquilla, Georgia Angeli, Christina Ntalla, Hamidou Cisse, Yuhana Sogoba, Gabriela M Guerra, Safiatou Doumbo, Didier Doumtabe, et al.

    Asymptomatic persistence is crucial for the survival of malaria parasites in seasonal transmission settings, where transmission halts during dry months, while mosquitos are scarce and new infections rare. How Plasmodium falciparum avoids causing host symptoms or being cleared is not fully understood. Parasites that persist through the dry season circulate longer within the ∼48h replication cycle compared to parasites isolated from clinical cases, where only early stages circulate. The mechanisms promoting increased circulation and avirulent infections bridging two wet seasons remain unclear. We generated a single-cell RNA-seq reference atlas with P. falciparum erythrocytic stages of a recently adapted isolate, and with it defined the developmental stage of over 25000 parasites from six asymptomatic children at the dry-wet season transition, and nine children with clinical malaria in the wet season. Our data confirms that older parasites circulate in the dry season, and reveals transcriptional modulation of exported proteins that affect cytoadhesion of infected erythrocytes, which we validated by immuno-fluorescence microscopy.


  • Open Access

    Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases

    by Sukai Ceesay, Martin Kampmann, Lasse Votborg-Novél, Helle Smedegaard Hansson, Rasmus Weisel Jensen, Manuela Carrasquilla, Hamidou Cisse, Louise Turner, Usama Dabbas, Christina Ntalla, et al.

    In seasonal transmission areas, clinical malaria occurs during the wet season when mosquitoes are present, while in the dry season, malaria transmission is interrupted and clinical cases are rare. In Mali, Plasmodium falciparum can persist in low parasitaemic asymptomatic individuals through the six-month dry season and shows reduced cytoadhesion of infected erythrocytes, evidenced by the circulation of further developed parasite stages compared to clinical malaria cases. How prolonged circulation of infected erythrocytes is achieved remains unknown. Here, we explored var gene expression in subclinical infections and clinical malaria cases of Malian children, collected during the dry and wet seasons. We sequenced expressed var DBLα-tags, used bioinformatic tools to predict their domain composition, binding phenotype and upstream sequence type; and determined their relationship to seasonality and clinical presentation. We found that parasites of asymptomatic infections expressed fewer var genes, with a larger proportion of var transcripts attributed to one or a few var s. In contrast, clinical cases exhibited expression of many var genes at lower proportions. We found that parasites of asymptomatic carriers expressed a mixture of CD36- and EPCR-binding PfEMP1, which changed over time. We confirmed that vars encoding CD36-binding PfEMP1 dominated in non-severe malaria cases, and found no significant difference in expressed var types between dry and wet seasons. Asymptomatic carriers were older, had higher titers of anti- P. falciparum antibodies, and broader reactivity to PfEMP1, suggesting that host immunity was the main determinant limiting var transcript variation in asymptomatic carriers. However, by RNAseq and qRT-PCR we also observed significantly higher total var transcript levels in malaria cases compared to asymptomatic carriers, suggesting that in addition to the parasite’s switching and the host’s immune selection of expressed var genes, parasites able to sustain long-term infections may be poised for reduced PfEMP1 expression.

  • Open Access

    Infection length and host environment influence on Plasmodium falciparum dry season reservoir

    by Carolina M Andrade, Manuela Carrasquilla, Usama Dabbas, Jessica Briggs, Hannah van Dijk, Nikolay Sergeev, Awa Sissoko, Moussa Niangaly, Christina Ntalla, Emily LaVerriere, et al.

    Persistence of malaria parasites in asymptomatic hosts is crucial in areas of seasonally-interrupted transmission, where P. falciparum bridges wet seasons months apart. During the dry season, infected erythrocytes exhibit extended circulation with reduced cytoadherence, increasing the risk of splenic clearance of infected cells and hindering parasitaemia increase. However, what determines parasite persistence for long periods of time remains unknown. Here, we investigated whether seasonality affects plasma composition so that P. falciparum can detect and adjust to changing serological cues; or if alternatively, parasite infection length dictates clinical presentation and persistency. Data from Malian children exposed to alternating ~6-month wet and dry seasons show that plasma composition is unrelated to time of year in non-infected children, and that carrying P. falciparum only minimally affects plasma constitution in asymptomatic hosts. Parasites persisting in the blood of asymptomatic children from the dry into the ensuing wet season rarely if ever appeared to cause malaria in their hosts as seasons changed. In vitro culture in the presence of plasma collected in the dry or the wet seasons did not affect parasite development, replication or host-cell remodelling. The absence of a parasite-encoded sensing mechanism was further supported by the observation of similar features in P. falciparum persisting asymptomatically in the dry season and parasites in age- and sex-matched asymptomatic children in the wet season. Conversely, we show that P. falciparum clones transmitted early in the wet season had lower chance of surviving until the end of the following dry season, contrasting with a higher likelihood of survival of clones transmitted towards the end of the wet season, allowing for the re-initiation of transmission. We propose that the decreased virulence observed in persisting parasites during the dry season is not due to the parasites sensing ability, nor is it linked to a decreased capacity for parasite replication but rather a consequence decreased cytoadhesion associated with infection length.


  • Open Access

    Iron transport pathways in the human malaria parasite Plasmodium falciparum revealed by RNA-sequencing

    by Juliane Wunderlich, Vadim Kotov, Lasse Votborg-Novél, Christina Ntalla, Maria Geffken, Sven Peine, Silvia Portugal, Jan Strauss

    Host iron deficiency is protective against severe malaria as the human malaria parasite Plasmodium falciparum depends on bioavailable iron from its host to proliferate. The essential pathways of iron acquisition, storage, export, and detoxification in the parasite differ from those in humans, as orthologs of the mammalian transferrin receptor, ferritin, or ferroportin, and a functional heme oxygenase are absent in P. falciparum . Thus, the proteins involved in these processes may be excellent targets for therapeutic development, yet remain largely unknown. Here, we show that parasites cultured in erythrocytes from an iron-deficient donor displayed significantly reduced growth rates compared to those grown in red blood cells from healthy controls. Sequencing of parasite RNA revealed diminished expression of genes involved in overall metabolism, hemoglobin digestion, and metabolite transport under low-iron versus control conditions. Supplementation with hepcidin, a specific ferroportin inhibitor, resulted in increased labile iron levels in erythrocytes, enhanced parasite replication, and transcriptional upregulation of genes responsible for merozoite motility and host cell invasion. Through endogenous GFP tagging of differentially expressed putative transporter genes followed by confocal live-cell imaging, proliferation assays with knockout and knockdown lines, and protein structure predictions, we identified six proteins that are likely required for ferrous iron transport in P. falciparum . Of these, we localized Pf VIT and Pf ZIPCO to cytoplasmic vesicles, Pf MRS3 to the mitochondrion, and the novel putative iron transporter Pf E140 to the plasma membrane for the first time in P. falciparum . Pf NRAMP/ Pf DMT1 and Pf CRT were previously reported to efflux Fe 2+ from the digestive vacuole. Our data support a new model for parasite iron homeostasis, in which Pf E140 is involved in iron uptake across the plasma membrane, Pf MRS3 ensures non-redundant Fe 2+ supply to the mitochondrion as the main site of iron utilization, Pf VIT transports excess iron into cytoplasmic vesicles, and Pf ZIPCO exports Fe 2+ from these organelles in case of iron scarcity. These results provide new insights into the parasite’s response to differential iron availability in its environment and into the mechanisms of iron transport in P. falciparum as promising candidate targets for future antimalarial drugs.


  • Top Cited Papers
    Open Access

    Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing

    by Mariateresa de Cesare, Mulenga Mwenda, Anna E. Jeffreys, Jacob Chirwa, Chris Drakeley, Kammerle Schneider, Brenda Mambwe, Karolina Glanz, Christina Ntalla, Manuela Carrasquilla, et al.

    Genomic surveillance of Plasmodium falciparum malaria can provide policy-relevant information about antimalarial drug resistance, diagnostic test failure, and the evolution of vaccine targets. Yet the large and low complexity genome of P. falciparum complicates the development of genomic methods, while resource constraints in malaria endemic regions can limit their deployment. Here, we demonstrate an approach for targeted nanopore sequencing of P. falciparum from dried blood spots (DBS) that enables cost-effective genomic surveillance of malaria in low-resource settings. We release software that facilitates flexible design of amplicon sequencing panels and use this software to design two target panels for P. falciparum. The panels generate 3–4 kbp reads for eight and sixteen targets respectively, covering key drug-resistance associated genes, diagnostic test antigens, polymorphic markers and the vaccine target csp. We validate our approach on mock and field samples, demonstrating robust sequencing coverage, accurate variant calls within coding sequences, the ability to explore P. falciparum within-sample diversity and to detect deletions underlying rapid diagnostic test failure.